Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
Sonnet BioTherapeutic | 10-Q: Quarterly report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | EFFECT: Others
Sonnet BioTherapeutic | CORRESP: CORRESP
Sonnet BioTherapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Markey(6.5%)
Sonnet BioTherapeutic | UPLOAD: Others
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | S-3: Registration statement for specified transactions by certain issuers
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic | 8-K: Current report
Sonnet BioTherapeutic: FY2023 Annual Report
Sonnet BioTherapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Markey(7.6%)
Sonnet BioTherapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Markey(6.4%)
Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Director Rao Raghu
Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Officer Mohan Pankaj
Sonnet BioTherapeutic | 424B4: Prospectus
No Data